As of May 22
| +0.09 / +2.96%|
The 1 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +123.64% increase from the last price of 3.13.
The current consensus among 2 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.